Skip to main content
. Author manuscript; available in PMC: 2015 Oct 1.
Published in final edited form as: Biol Res Nurs. 2014 Jan 30;16(4):438–447. doi: 10.1177/1099800413519495

Table 1.

Demographic and Medical History Characteristics of Participants by Group.

Characteristic Total (N = 142) Usual Care (N = 68) MBSR(BC) (N = 74) p value
Mean age (SD), years 55.31 (9.84) 55.19 (9.15) 55.42 (10.49) .89
Mean days since the end of adjuvant treatment (SD) 238 (224) 212 (258) 261 (187) .20
Race/ethnicity, n (%) .71
 White, non-Hispanic 101 (71.1) 49 (72.1) 52 (70.3) .55
 White, Hispanic 15 (10.6) 7 (10.3) 8 (10.8) .47
 Black, non-Hispanic 17 (12.0) 10 (14.7) 7 (9.5) .24
 Other 9 (5.6) 2 (3.0) 7 (9.5) .13
Educational status, n (%)a .87
 High school or less 24 (17.0) 12 (17.9) 12 (16.2)
 Some college 57 (40.4) 28 (41.8) 29 (39.2)
 College or professional degrees 60 (42.6) 27 (40.3) 33 (44.6)
Employment status, n (%)a .07
 Employed 60 (42.6) 34 (50.7) 26 (35.1)
 Retired 31 (22.0) 11 (16.4) 20 (27.0)
 Disabled/medical leave 13 (9.2) 4 (6.0) 9 (12.2)
 Unemployed 17 (12.1) 11 (16.4) 6 (8.1)
 Other 20 (14.2) 7 (10.4) 13 (17.6)
Breast cancer stage, n (%) .41
 Stage 0 14 (9.9) 8 (11.8) 6 (8.1)
 Stage I 57 (40.1) 31 (45.6) 26 (35.1)
 Stage II 54 (38.0) 22 (32.4) 32 (43.2)
 Stage III 17 (12.0) 7 (10.3) 10 (13.5)
Adjuvant treatment type, n (%) .57
 Chemotherapy 24 (16.9) 14 (20.6) 10 (13.5)
 Radiation 35 (24.6) 17 (25.0) 18 (24.3)
 Chemotherapy and radiation 51 (35.9) 21 (30.9) 30 (40.5)
 None 32 (22.5) 16 (23.5) 16 (21.6)
Surgery type, n (%) .87
 Lumpectomy 60 (42.3) 28 (41.2) 32 (43.2)
 Mastectomy 82 (57.7) 40 (58.8) 42 (56.8)
Comorbidities, n (%) .37
 Diabetes 15 (14.4) 8 (15.7) 7 (13.2)
 Cardiovascular problems 9 (6.3) 3 (4.4) 6 (8.1)

Note. MBSR(BC) = mindfulness-based stress reduction intervention for breast cancer survivors.

a

One usual care participant did not respond to the questions on education or employment.